MDS Nordion gets regulatory approvals

Canadian isotope supplier MDS Nordion has received regulatory go-aheads from the U.S. Food and Drug Administration and the Health Canada agency for its Monte Carlo electron-radiotherapy treatment-calculation technique. According to the Kanata, Ontario vendor, the software will provide greater accuracy in calculating the dose required for cancer patients receiving radiation therapy. The company will be using the dose-calculation algorithms in its Oncentra treatment-planning software.

By staff writers
July 11, 2002

Related Reading

MDS Nordion focuses on oncology software solutions, June 28, 2002

Varian to buy MDS Nordion's brachytherapy unit, June 27, 2002

MDS expands manufacturing facilities, June 12, 2002

MDS Nordion shows oncology info management system, November 5, 2001

Copyright © 2002

Page 1 of 461
Next Page